New method of radiation treatment may improve the local control of breast cancer

A new method of radiation treatment may improve the local control of breast cancer significantly which, is very important to cancer sufferers because it can preserve the breast and may also reduce the spread of the disease.

The direct application of radiation to the tumor or tumor bed while a patient is undergoing surgery for breast cancer can improve survival rates. This practice known as Intraoperative Radiation Treatment (IORT) it starts therapy at the time of surgery when residual tumor cells are most active.

Developed by Intraop Medical Corporation, the Mobetron is an FDA approved innovative machine that delivers intraoperative radiation therapy in a regular OR. IORT is believed to be an effective treatment to improve cancer survival rates because a single two-minute treatment can often eliminate several weeks of conventional pre- or post-operative external beam radiation therapy.

Experts at Intraop devised the first mobile device for delivering radiation in the operating room without the necessity of adding extensive radiation shielding.

"There is a typical wait of 4-6 weeks after lumpectomy before the initiation of adjuvant radiation therapy. During this waiting period, there is ample opportunity for the microscopic tumor cells that remain in the breast cavity to reimplant and become viable or to disseminate elsewhere in the body, resulting in metastases," said Don Goer, Chief Executive Officer for Intraop Medical Corporation.

IORT is being used for breast cancer in Europe where over 2500 women have been treated, as well as in the United States -- The Mayo Clinic, Scottsdale Arizona and the University of North Carolina at Chapel Hill are two of four U.S. medical centers that have initiated a breast cancer IORT program due in part to the encouraging early results in Europe.

The Mobetron is FDA approved in the United States and has received the equivalent foreign approvals. IORT could really make a big difference to many women who suffer from breast cancer, and provide them with hope for the future.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
AI-based liquid biopsy technology promises early detection of cancer recurrence